Biohit Oyj

Report Publication Announcement • Dec 5, 2016

Disclosure 347374

Biohit Oyj - Financial Calendar

Biohit Oyj’s Financial Reporting and Annual General Meeting in 2017

Biohit Oyj Stock Exchange Release, December 5, 2016 at 3:00 pm local time (EET) -- Biohit Oyj will release its financial statements for 2016 on Monday 20 th of February 2017 at 9:30 am. -- The Annual Report, which contains the Financial Statements for 2016 and the Report of the Board of Directors, will be published approximately during week 12. -- Biohit Oyj’s Annual General Meeting has been planned for Wednesday 26th of April 2017 at 5:00 pm. The Board of Directors will call the General Meeting at a later date. -- Half year financial report for period January-June (H1) 2017 on Thursday 17th of August 2017 at 9:30 am. The published economic reports and other stock exchange releases are available on Biohit's website at www.biohithealthcare.com/investors. The website also contains an online form for ordering electronic copies, which will be e-mailed to you, available at http://www.biohithealthcare.com/investors/stock-exchange-releases/order-releases -to-your-email. Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com